Comparison of pembrolizumab dosing regimens and incidence and severity of immune-related adverse effects: A retrospective, case-control study. - Monson T; Cascone VJ; Diaz FJ; Dai J; Doolittle GC (American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2026)